查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947822

空间基因组学和转录组学市场分析及预测（至2035年）：按类型、产品类型、服务、技术、应用、最终用户、组件、流程、功能划分

Spatial Genomics and Transcriptomics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Process, Functionality
出版日期: | 出版商: Global Insight Services | 英文 359 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计空间基因组学和转录组学市场将从2024年的5.825亿美元成长到2034年的14.235亿美元，复合年增长率约为10.4%。该市场涵盖了在组织空间背景下绘製基因活性和表达图谱的技术。这些解决方案能够揭示细胞异质性和组织结构，这对理解复杂的生物学过程至关重要。影像、定序和数据分析技术的进步正在推动这个市场的发展，为疾病机制和治疗标靶的研究提供了新的视角，其应用领域涵盖肿瘤学、神经科学和发育生物学。

空间基因组学和转录组学市场正经历强劲成长，这主要得益于单细胞分析和空间解析度技术的进步。耗材领域成长率最高，主要得益于空间分析工作流程中必需的试剂和试剂盒的日益普及。其次是仪器领域，影像系统和定序平台的出现增强了资料撷取能力。在耗材领域，试剂子领域占据主导地位，这反映了其在实现精确空间分析方面的重要作用。针对特定研究需求的标靶检测试剂盒正迅速崛起，成为第二大增长点。在仪器领域，空间成像系统凭藉其对细胞环境的高解析度分析能力而处于主导。支援全面转录组分析的定序平台是第二大成长驱动力。此外，市场还受到对能够提高工作流程效率和数据准确性的整合解决方案的需求不断增长的推动。人们对多组体学方法的日益关注正在促进整个行业的创新与合作，为研发领域创造新的机会。

市场区隔
类型 空间基因组学，空间转录组学
产品 设备、耗材和软体
服务 样品製备、数据分析、咨询
科技 基于成像、定序定序
应用领域 癌症研究、神经科学、免疫学、药物发现、发育生物学
最终用户 学术和研究机构、製药和生物技术公司、医院和诊所
成分 硬体、软体和服务
过程 单细胞分析、组织层次分析
功能 数据视觉化、数据集成

空间基因组学和转录组学市场正经历动态变化，创新的定价策略和新产品的推出导致市场份额不断转移。各公司正利用先进技术提升产品和服务，并专注于准确性和扩充性。竞争格局的特点是不断涌现新的解决方案，以满足日益增长的对高空间分辨率和全面转录组分析的需求。市场拥有强大的产品线，反映出各公司致力于满足基因组研究不断变化的需求。空间基因组学和转录组学市场的竞争异常激烈，主要参与者透过策略联盟和技术创新争夺主导。监管影响，尤其是在北美和欧洲，在确保合规性和标准化以及塑造市场动态发挥关键作用。肿瘤学、神经病学和发育生物学等多元化的应用领域进一步丰富了市场，促进了这些技术的应用。随着监管环境的不断变化，各公司也在不断调整以确保合规性，从而增强自身竞争优势并推动市场成长。

主要趋势和驱动因素：

空间基因组学和转录组学市场正经历强劲成长，这主要得益于单细胞分析技术的进步。这些创新使研究人员能够以前所未有的精准度探索细胞异质性。一个关键趋势是将空间资讯与基因组数据结合，从而深入了解组织结构和细胞间相互作用。这种整合正在彻底改变我们对复杂生物系统和疾病机制的理解。另一个关键驱动因素是对个人化医疗日益增长的需求。随着医学朝着个人化治疗方法发展，空间基因组学和转录组学为制定治疗策略提供了至关重要的数据。研究人员和临床医生正在利用这些技术，透过生物标记识别和标靶治疗来改善患者的治疗效果。学术机构和生物技术公司之间日益密切的合作也透过加速研发推动了市场成长。此外，空间基因体学在药物发现领域的应用也值得关注。製药公司正在利用这些技术来识别新的药物靶点，并在细胞层面上阐明药物的作用机制。预计这种应用将缩短药物研发的时间并降低成本。此外，政府和私人机构对生命科学研究的投入不断增加，促进了太空基因组学和转录组学技术在各个领域的广泛应用。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 空间基因体学
    • 空间转录组学
  • 市场规模及预测：依产品划分
    • 装置
    • 消耗品
    • 软体
  • 市场规模及预测：依服务划分
    • 样品製备
    • 数据分析
    • 咨询
  • 市场规模及预测：依技术划分
    • 成像基地
    • 定序定序
  • 市场规模及预测：依应用领域划分
    • 癌症研究
    • 神经科学
    • 免疫学
    • 药物发现
    • 发育生物学
  • 市场规模及预测：依最终用户划分
    • 学术和研究机构
    • 製药和生物技术公司
    • 医院和诊所
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
    • 服务
  • 市场规模及预测：依製程划分
    • 单细胞分析
    • 组织层级分析
  • 市场规模及预测：依功能划分
    • 数据视觉化
    • 数据集成

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • 10x Genomics
  • Nano String Technologies
  • Akoya Biosciences
  • Vizgen
  • Resolve Biosciences
  • Spatial Transcriptomics AB
  • Bio-Techne
  • Ultivue
  • Rebus Biosystems
  • Rare Cyte
  • Advanced Cell Diagnostics
  • Canopy Biosciences
  • Genomic Vision
  • CARTANA
  • Celsee
  • Kroma Ti D
  • Hyb & Seq Technologies
  • Read Coor
  • Molecular Instruments
  • Quantapore

第九章：关于我们

简介目录
Product Code: GIS325701

Spatial Genomics and Transcriptomics Market is anticipated to expand from $582.5 million in 2024 to $1,423.5 million by 2034, growing at a CAGR of approximately 10.4%. The Spatial Genomics and Transcriptomics Market encompasses technologies that map gene activity and expression within the spatial context of tissues. These solutions reveal cellular heterogeneity and tissue architecture, crucial for understanding complex biological processes. Advancements in imaging, sequencing, and data analysis drive this market, offering insights into disease mechanisms and therapeutic targets, with applications spanning oncology, neuroscience, and developmental biology.

The Spatial Genomics and Transcriptomics Market is experiencing robust growth, fueled by advancements in single-cell analysis and spatial resolution technologies. The consumables segment is the top performer, driven by increased adoption of reagents and kits essential for spatial analysis workflows. Instruments follow closely, with imaging systems and sequencing platforms enhancing data acquisition capabilities. Within consumables, the reagents sub-segment outpaces others, reflecting their critical role in enabling precise spatial profiling. Kits for targeted assays are emerging as a strong second, catering to specific research needs. In instruments, spatial imaging systems lead, offering high-resolution insights into cellular environments. Sequencing platforms are gaining momentum as the second-highest performers, supporting comprehensive transcriptomic analysis. The market is further bolstered by the rising demand for integrated solutions that streamline workflows and improve data accuracy. Growing interest in multi-omics approaches is driving innovation and collaboration across the sector, unlocking new opportunities for research and development.

Market Segmentation
TypeSpatial Genomics, Spatial Transcriptomics
ProductInstruments, Consumables, Software
ServicesSample Preparation, Data Analysis, Consulting
TechnologyImaging-Based, Sequencing-Based
ApplicationCancer Research, Neuroscience, Immunology, Drug Discovery, Developmental Biology
End UserAcademic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics
ComponentHardware, Software, Services
ProcessSingle-Cell Analysis, Tissue-Level Analysis
FunctionalityData Visualization, Data Integration

The Spatial Genomics and Transcriptomics Market is experiencing a dynamic shift, with market share being influenced by innovative pricing strategies and the introduction of new products. Companies are leveraging advanced technologies to enhance their offerings, focusing on precision and scalability. The competitive landscape is marked by the emergence of novel solutions that cater to the increasing demand for detailed spatial resolution and comprehensive transcriptomic profiling. This market is characterized by a robust pipeline of product launches, reflecting a commitment to addressing the evolving needs of genomic research. Competition in the Spatial Genomics and Transcriptomics Market is intense, with key players vying for dominance through strategic alliances and technological advancements. Regulatory influences, particularly in North America and Europe, play a pivotal role in shaping market dynamics, ensuring compliance and standardization. The market is further enriched by a diverse range of applications spanning oncology, neurology, and developmental biology, driving the adoption of these technologies. As the regulatory landscape evolves, companies are adapting to ensure alignment, thereby enhancing their competitive edge and fostering market growth.

Geographical Overview:

The Spatial Genomics and Transcriptomics Market is witnessing dynamic growth across various global regions, each presenting unique opportunities. North America leads with substantial research funding and advanced healthcare infrastructure. The region's focus on precision medicine and genomics propels market expansion. Europe follows, driven by robust academic research and government initiatives supporting genomics. The emphasis on personalized healthcare solutions enhances market potential. In Asia Pacific, the market is rapidly expanding due to technological advancements and rising healthcare investments. Countries like China and India are emerging as key players, supported by government initiatives and increasing genomic research. Latin America and the Middle East & Africa are burgeoning markets with untapped potential. In Latin America, rising healthcare expenditure and genomic research investments are notable. Meanwhile, the Middle East & Africa recognize the significance of genomics in healthcare innovation, driving market interest and development. These regions represent promising growth pockets for the industry.

The Spatial Genomics and Transcriptomics Market is navigating complex global tariffs and geopolitical risks, particularly in East Asia. Japan and South Korea are mitigating tariff impacts by fostering innovation in spatial analysis technologies, while China accelerates domestic capabilities amid export restrictions. Taiwan, pivotal in semiconductor supply, faces geopolitical vulnerabilities due to US-China tensions. The broader genomics market is robust, driven by advancements in personalized medicine and bioinformatics. By 2035, the market is expected to flourish, contingent on resilient supply chains and strategic collaborations. Middle East conflicts may exacerbate global supply chain disruptions and elevate energy prices, influencing production costs and timelines. East Asian strategies increasingly focus on self-reliance and regional partnerships to navigate trade tensions and ensure market stability.

Key Trends and Drivers:

The Spatial Genomics and Transcriptomics Market is experiencing robust growth, fueled by advancements in single-cell analysis technologies. These innovations are enabling researchers to explore cellular heterogeneity with unprecedented precision. A key trend is the integration of spatial information with genomic data, offering insights into tissue architecture and cellular interactions. This integration is revolutionizing our understanding of complex biological systems and disease mechanisms. Another significant driver is the increasing demand for personalized medicine. As healthcare moves towards tailored therapeutic approaches, spatial genomics and transcriptomics provide critical data that inform treatment strategies. Researchers and clinicians are leveraging these technologies to identify biomarkers and develop targeted therapies, enhancing patient outcomes. The rise of collaborations between academic institutions and biotechnology companies is also propelling market growth by accelerating research and development efforts. Moreover, the expanding application of spatial genomics in drug discovery is noteworthy. Pharmaceutical companies are utilizing these technologies to identify novel drug targets and understand drug mechanisms at a cellular level. This application is expected to reduce drug development timelines and costs. Additionally, the growing investment in life sciences research, supported by governmental and private funding, is facilitating the adoption of spatial genomics and transcriptomics technologies across various sectors.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Spatial Genomics
    • 4.1.2 Spatial Transcriptomics
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Consumables
    • 4.2.3 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sample Preparation
    • 4.3.2 Data Analysis
    • 4.3.3 Consulting
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Imaging-Based
    • 4.4.2 Sequencing-Based
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Cancer Research
    • 4.5.2 Neuroscience
    • 4.5.3 Immunology
    • 4.5.4 Drug Discovery
    • 4.5.5 Developmental Biology
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Academic & Research Institutions
    • 4.6.2 Pharmaceutical & Biotechnology Companies
    • 4.6.3 Hospitals & Clinics
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Services
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Single-Cell Analysis
    • 4.8.2 Tissue-Level Analysis
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Data Visualization
    • 4.9.2 Data Integration

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 10x Genomics
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Nano String Technologies
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Akoya Biosciences
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Vizgen
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Resolve Biosciences
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Spatial Transcriptomics AB
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Bio- Techne
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ultivue
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Rebus Biosystems
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Rare Cyte
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Advanced Cell Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Canopy Biosciences
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Genomic Vision
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 CARTANA
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Celsee
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Kroma Ti D
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Hyb & Seq Technologies
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Read Coor
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Molecular Instruments
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Quantapore
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us